Reported Earnings • Mar 21
Full year 2025 earnings released: ₩800 loss per share (vs ₩621 profit in FY 2024) Full year 2025 results: ₩800 loss per share (down from ₩621 profit in FY 2024). Revenue: ₩574.9b (down 6.6% from FY 2024). Net loss: ₩22.7b (down 226% from profit in FY 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Announcement • Mar 07
KOLMAR BNH Co.,Ltd., Annual General Meeting, Mar 31, 2026 KOLMAR BNH Co.,Ltd., Annual General Meeting, Mar 31, 2026, at 09:00 Tokyo Standard Time. Location: conference room, 89, miraesandan-ro, jeonui-myeon, sejong South Korea Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₩11,780, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 51% over the past three years. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩14,630, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 21x in the Personal Products industry in South Korea. Total loss to shareholders of 47% over the past three years. New Risk • Aug 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 32% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (dividend per share is over 6x cash flows per share). Share price has been volatile over the past 3 months (9.3% average weekly change). Profit margins are more than 30% lower than last year (2.1% net profit margin). Valuation Update With 7 Day Price Move • Aug 20
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₩17,700, the stock trades at a trailing P/E ratio of 39.5x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 25% over the past three years. New Risk • May 29
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 3.3% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 32% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (dividend per share is over 6x cash flows per share). Profit margins are more than 30% lower than last year (2.1% net profit margin). Reported Earnings • Mar 20
Full year 2024 earnings released: EPS: ₩621 (vs ₩674 in FY 2023) Full year 2024 results: EPS: ₩621 (down from ₩674 in FY 2023). Revenue: ₩615.6b (up 6.2% from FY 2023). Net income: ₩18.1b (down 8.4% from FY 2023). Profit margin: 2.9% (down from 3.4% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Announcement • Nov 14
KOLMAR BNH Co.,Ltd. (KOSDAQ:A200130) announces an Equity Buyback for KRW 10,000 million worth of its shares. KOLMAR BNH Co.,Ltd. (KOSDAQ:A200130) announces a share repurchase program. Under the program, the company will repurchase up to KRW 10,000 million worth of its shares according to the contract with Daeshin Securities. The purpose of the program is stock Price stabilization and Increase shareholder value. The program will expire on May 14, 2025. As of November 12, 2024, the company had 296,500 and 2,166 treasury stock holdings in acquisition within the scope of allotment and through other acquisition, respectively. Valuation Update With 7 Day Price Move • Nov 13
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩11,650, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 18x in the Personal Products industry in South Korea. Total loss to shareholders of 63% over the past three years. Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩18,990, the stock trades at a trailing P/E ratio of 27.6x. Average trailing P/E is 28x in the Personal Products industry in South Korea. Total loss to shareholders of 61% over the past three years. New Risk • May 24
New major risk - Revenue and earnings growth Earnings have declined by 11% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 11% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.4% net profit margin). Reported Earnings • Mar 22
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: ₩674 (down from ₩1,371 in FY 2022). Revenue: ₩579.6b (flat on FY 2022). Net income: ₩19.7b (down 51% from FY 2022). Profit margin: 3.4% (down from 7.0% in FY 2022). Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) also missed analyst estimates by 43%. Revenue is forecast to grow 7.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 36% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Dec 20
Upcoming dividend of ₩308 per share at 1.7% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 26 April 2024. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 1.7%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.2%). Reported Earnings • Mar 26
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: ₩1,371 (down from ₩2,365 in FY 2021). Revenue: ₩575.9b (down 2.9% from FY 2021). Net income: ₩40.5b (down 42% from FY 2021). Profit margin: 7.0% (down from 12% in FY 2021). The decrease in margin was primarily driven by lower revenue. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) also missed analyst estimates by 21%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 8.9% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Buying Opportunity • Mar 08
Now 21% undervalued Over the last 90 days, the stock is up 1.4%. The fair value is estimated to be ₩31,723, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 26% in 2 years. Earnings is forecast to grow by 46% in the next 2 years. Announcement • Jan 27
Kolmar BNH Co., Ltd. (KOSDAQ:A200130) announces an Equity Buyback for KRW 10,000 million worth of its shares. Kolmar BNH Co., Ltd. (KOSDAQ:A200130) announces a share repurchase program. Under the program, the company will repurchase up to $10,000 million worth of its shares according to the contract with NH Investment & Securities. The purpose of the program is shareholder value enhancement. The program will expire on July 27, 2023. As of January 26, 2023, the company had 0 and 2,166 treasury stock holdings in acquisition within the scope of allotment and through other acquisition, respectively. Buying Opportunity • Dec 28
Now 21% undervalued Over the last 90 days, the stock is up 28%. The fair value is estimated to be ₩36,234, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 28% in 2 years. Earnings is forecast to grow by 45% in the next 2 years. Valuation Update With 7 Day Price Move • Dec 27
Investor sentiment improved over the past week After last week's 17% share price gain to ₩29,300, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 7.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩36,167 per share. Upcoming Dividend • Dec 21
Upcoming dividend of ₩385 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 18 April 2023. Payout ratio is a comfortable 21% but the company is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (1.3%). Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment improved over the past week After last week's 17% share price gain to ₩25,950, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 4.6% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩39,891 per share. Price Target Changed • Nov 16
Price target decreased to ₩41,500 Down from ₩75,400, the current price target is an average from 2 analysts. New target price is 74% above last closing price of ₩23,850. Stock is down 27% over the past year. The company is forecast to post earnings per share of ₩1,979 for next year compared to ₩2,365 last year. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Price Target Changed • Apr 27
Price target decreased to ₩45,500 Down from ₩75,400, the current price target is an average from 2 analysts. New target price is 36% above last closing price of ₩33,400. Stock is down 34% over the past year. The company is forecast to post earnings per share of ₩2,568 for next year compared to ₩2,365 last year. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Feb 21
Investor sentiment improved over the past week After last week's 18% share price gain to ₩35,900, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total returns to shareholders of 24% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩320 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 12 April 2022. Payout ratio is a comfortable 14% but the company is paying out more than the cash it is generating. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (0.8%). Price Target Changed • Sep 03
Price target decreased to ₩68,750 Down from ₩75,400, the current price target is an average from 4 analysts. New target price is 73% above last closing price of ₩39,650. Stock is down 39% over the past year. Valuation Update With 7 Day Price Move • Aug 20
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩38,450, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩72,049 per share. Major Estimate Revision • May 31
Consensus EPS estimates fall to ₩3,231 The consensus outlook for earnings per share (EPS) in 2021 has deteriorated. 2021 revenue forecast decreased from ₩769.1m to ₩743.0m. EPS estimate also fell from ₩3,592 to ₩3,231. Net income forecast to grow 23% next year vs 50% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩76,000 unchanged from last update. Share price was steady at ₩52,900 over the past week. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improved over the past week After last week's 16% share price gain to ₩56,800, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 22x in the Personal Products industry in South Korea. Total returns to shareholders of 82% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩86,400 per share. Reported Earnings • Mar 17
Full year 2020 earnings released: EPS ₩2,724 (vs ₩1,844 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: ₩606.9b (up 38% from FY 2019). Net income: ₩80.5b (up 48% from FY 2019). Profit margin: 13% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 19% per year. Announcement • Mar 11
KOLMAR BNH Co., Ltd., Annual General Meeting, Mar 19, 2021 KOLMAR BNH Co., Ltd., Annual General Meeting, Mar 19, 2021. Is New 90 Day High Low • Mar 10
New 90-day low: ₩48,750 The company is down 8.0% from its price of ₩52,800 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩86,946 per share. Price Target Changed • Mar 06
Price target lowered to ₩77,800 Down from ₩84,667, the current price target is an average from 3 analysts. The new target price is 58% above the current share price of ₩49,250. As of last close, the stock is up 78% over the past year. Is New 90 Day High Low • Jan 29
New 90-day low: ₩49,000 The company is down 6.0% from its price of ₩51,900 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩110,199 per share. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩250 Per Share Will be paid on the 13th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.5% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.6%). Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment improved over the past week After last week's 17% share price gain to ₩57,400, the stock is trading at a trailing P/E ratio of 22.3x, up from the previous P/E ratio of 19.1x. This compares to an average P/E of 35x in the Personal Products industry in South Korea. Total returns to shareholders over the past three years are 104%. Is New 90 Day High Low • Nov 10
New 90-day low: ₩50,000 The company is down 22% from its price of ₩64,200 on 12 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩99,910 per share. Major Estimate Revision • Oct 29
Analysts update estimates The 2020 consensus earning per share (EPS) estimate increased from ₩2,702 to ₩3,415. Revenue estimate for the same period was approximately flat at ₩641.1m. Net income is expected to grow by 47% next year compared to 73% growth forecast for the Personal Products industry in South Korea. The consensus price target increased from ₩71,500 to ₩80,333. Share price is down by 2.0% to ₩57,900 over the past week. Price Target Changed • Oct 28
Price target raised to ₩80,333 Up from ₩67,800, the current price target is an average from 6 analysts. The new target price is 36% above the current share price of ₩58,900. As of last close, the stock is up 118% over the past year. Is New 90 Day High Low • Oct 26
New 90-day low: ₩55,500 The company is down 13% from its price of ₩63,500 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩88,977 per share.